Previous Article | Next Article 
Journal of Virology, February 2005, p. 2050-2057, Vol. 79, No. 4
0022-538X/05/$08.00+0 doi:10.1128/JVI.79.4.2050-2057.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
Role of CCL11 in Eosinophilic Lung Disease during Respiratory Syncytial Virus Infection
Stephen P. Matthews ,1,
,
John S. Tregoning,1,
Anthony J. Coyle,2
Tracy Hussell,1,
and
Peter J. M. Openshaw1*
Department of Respiratory Medicine, National Heart and Lung Institute, Faculty of Medicine, Imperial College London, London, United Kingdom,1
Department of Biology, Inflammation Division, Millennium Pharmaceuticals, Incorporated, Cambridge, Massachusetts2
Received 27 May 2004/
Accepted 4 October 2004
Respiratory syncytial virus (RSV) is a major viral pathogen of infants and the elderly. Significant morbidity is caused by an overexuberant mixed lung cell infiltrate, which is thought to be driven by chemokines. One of the main chemotactic mediators responsible for the movement of eosinophils is CCL11 (eotaxin). Using a mouse model of eosinophilic bronchiolitis induced by RSV, we show here that treatment in vivo with a blocking antibody to CCL11 greatly reduces lung eosinophilia and disease severity. In addition, anti-CCL11 caused a striking inhibition of CD4-T-cell influx and shifted cytokine production away from interleukin-5 without reducing the resistance to viral replication. These results suggest that in addition to influencing eosinophil diapedesis and survival, anti-CCL11 has an action on T cells. These studies strengthen the case for anti-CCL11 treatment of Th2-driven diseases.
* Corresponding author. Mailing address: Department of Respiratory Medicine, National Heart and Lung Institute, Faculty of Medicine, Imperial College, London W2 1PG, United Kingdom. Phone: (44) 20 7594 3854. Fax: (44) 20 7262 8913. E-mail:
p.openshaw{at}imperial.ac.uk.
S.P.M. and J.S.T. contributed equally to this work.
Present address: Division of Cell Biology and Immunology, Wellcome Trust Biocentre, University of Dundee, Dundee DD1 5EH, United Kingdom.
Present address: Centre for Molecular Microbiology and Infection (CMMI), Biological Sciences, Imperial College London, London SW7 2AZ, United Kingdom.
Journal of Virology, February 2005, p. 2050-2057, Vol. 79, No. 4
0022-538X/05/$08.00+0 doi:10.1128/JVI.79.4.2050-2057.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Dodd, J. S., Lum, E., Goulding, J., Muir, R., Van Snick, J., Openshaw, P. J. M.
(2009). IL-9 Regulates Pathology during Primary and Memory Responses to Respiratory Syncytial Virus Infection. J. Immunol.
183: 7006-7013
[Abstract]
[Full Text]
-
Olson, M. R., Hartwig, S. M., Varga, S. M.
(2008). The Number of Respiratory Syncytial Virus (RSV)-Specific Memory CD8 T Cells in the Lung Is Critical for Their Ability to Inhibit RSV Vaccine-Enhanced Pulmonary Eosinophilia. J. Immunol.
181: 7958-7968
[Abstract]
[Full Text]
-
Wu, P., Dupont, W. D., Griffin, M. R., Carroll, K. N., Mitchel, E. F., Gebretsadik, T., Hartert, T. V.
(2008). Evidence of a Causal Role of Winter Virus Infection during Infancy in Early Childhood Asthma. Am. J. Respir. Crit. Care Med.
178: 1123-1129
[Abstract]
[Full Text]
-
Johnson, T. R., Rothenberg, M. E., Graham, B. S.
(2008). Pulmonary eosinophilia requires interleukin-5, eotaxin-1, and CD4+ T cells in mice immunized with respiratory syncytial virus G glycoprotein. J. Leukoc. Biol.
84: 748-759
[Abstract]
[Full Text]
-
Tregoning, J. S., Yamaguchi, Y., Harker, J., Wang, B., Openshaw, P. J. M.
(2008). The Role of T Cells in the Enhancement of Respiratory Syncytial Virus Infection Severity during Adult Reinfection of Neonatally Sensitized Mice. J. Virol.
82: 4115-4124
[Abstract]
[Full Text]
-
Castilow, E. M., Meyerholz, D. K., Varga, S. M.
(2008). IL-13 Is Required for Eosinophil Entry into the Lung during Respiratory Syncytial Virus Vaccine-Enhanced Disease. J. Immunol.
180: 2376-2384
[Abstract]
[Full Text]
-
Phipps, S., Lam, C. E., Mahalingam, S., Newhouse, M., Ramirez, R., Rosenberg, H. F., Foster, P. S., Matthaei, K. I.
(2007). Eosinophils contribute to innate antiviral immunity and promote clearance of respiratory syncytial virus. Blood
110: 1578-1586
[Abstract]
[Full Text]
-
Niimi, K., Asano, K., Shiraishi, Y., Nakajima, T., Wakaki, M., Kagyo, J., Takihara, T., Suzuki, Y., Fukunaga, K., Shiomi, T., Oguma, T., Sayama, K., Yamaguchi, K., Natori, Y., Matsumoto, M., Seya, T., Yamaya, M., Ishizaka, A.
(2007). TLR3-Mediated Synthesis and Release of Eotaxin-1/CCL11 from Human Bronchial Smooth Muscle Cells Stimulated with Double-Stranded RNA. J. Immunol.
178: 489-495
[Abstract]
[Full Text]
-
Culley, F. J., Pennycook, A. M. J., Tregoning, J. S., Dodd, J. S., Walzl, G., Wells, T. N., Hussell, T., Openshaw, P. J. M.
(2006). Role of CCL5 (RANTES) in Viral Lung Disease.. J. Virol.
80: 8151-8157
[Abstract]
[Full Text]
-
Culley, F. J., Pennycook, A. M. J., Tregoning, J. S., Hussell, T., Openshaw, P. J. M.
(2006). Differential Chemokine Expression following Respiratory Virus Infection Reflects Th1- or Th2-Biased Immunopathology. J. Virol.
80: 4521-4527
[Abstract]
[Full Text]
-
Openshaw, P. J. M., Tregoning, J. S.
(2005). Immune Responses and Disease Enhancement during Respiratory Syncytial Virus Infection. Clin. Microbiol. Rev.
18: 541-555
[Abstract]
[Full Text]